Research graph
References from Association of IVCF use with mortality and intracranial hemorrhage in patients with selected cancers and brain metastasis. Local targets link to admitted publications; unresolved targets remain external evidence.
Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy
10.1111/j.1538-7836.2007.02374.x · 2007 · External reference
Intracranial hemorrhage in patients with brain metastases treated with therapeutic enoxaparin: a matched cohort study
10.1182/blood-2015-02-626788 · 2015 · External reference
Outcomes after inferior vena cava filter placement in cancer patients diagnosed with pulmonary embolism: risk for recurrent venous thromboembolism
10.1007/s11239-017-1557-2 · 2017 · External reference
A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group
10.1056/nejm199802123380701 · 1998 · External reference
Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d'Embolie Pulmonaire par Interruption Cave) randomized study
10.1161/circulationaha.104.512834 · 2005 · External reference
Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update
10.1200/jco.19.01461 · 2020 · External reference
Current controversies in inferior vena cava filter placement
10.2214/ajr.20.24817 · 2021 · External reference
Risk of intracranial hemorrhage with anticoagulation therapy in melanoma patients with brain metastases
10.1097/cmr.0b013e328353efd8 · 2012 · External reference
A meta-analysis of intracranial hemorrhage in patients with brain tumors receiving therapeutic anticoagulation
10.1111/jth.13387 · 2016 · External reference
Intracranial hemorrhage with direct oral anticoagulants in patients with brain tumors
10.1111/jth.14336 · 2019 · External reference
American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism
10.1182/bloodadvances.2020001830 · 2020 · External reference
Antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report
10.1016/j.chest.2021.07.055 · 2021 · External reference
Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism: a randomized clinical trial
10.1001/jama.2015.3780 · 2015 · External reference
A multicenter trial of vena cava filters in severely injured patients
10.1056/nejmoa1806515 · 2019 · External reference
Association of inferior vena cava filter placement for venous thromboembolic disease and a contraindication to anticoagulation with 30-day mortality
10.1001/jamanetworkopen.2018.0452 · 2018 · External reference
Systems-based hematology: highlighting successes and next steps
10.1182/bloodadvances.2020002947 · 2020 · External reference
Inferior vena cava filters in patients with cancer and venous thromboembolism (VTE): patterns of use and outcomes
10.1016/s0049-3848(16)30112-8 · 2016 · External reference
Association of inferior vena cava filter placement with rates of pulmonary embolism in patients with cancer and acute lower extremity deep venous thrombosis
10.1001/jamanetworkopen.2020.11079 · 2020 · External reference
Association of inferior vena cava filter use with mortality rates in older adults with acute pulmonary embolism
10.1001/jamainternmed.2018.5287 · 2019 · External reference
Socioeconomic status and breast cancer incidence in California for different race/ethnic groups
2001 · External reference
Unresolved reference
2011 · External reference
Predictive value of the present-on-admission indicator for hospital-acquired venous thromboembolism
10.1097/mlr.0b013e318286e34f · 2015 · External reference
Comorbidity measures for use with administrative data
10.1097/00005650-199801000-00004 · 1998 · External reference
Outcomes after vena cava filter use in noncancer patients with acute venous thromboembolism: a population-based study
10.1161/circulationaha.115.020338 · 2016 · External reference
Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples
10.1002/sim.3697 · 2009 · External reference
Using inverse probability-weighted estimators in comparative effectiveness analyses with observational databases
10.1097/mlr.0b013e31806518ac · 2007 · External reference
Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes
10.1136/bmj.b5087 · 2010 · External reference
Apixaban for the treatment of venous thromboembolism associated with cancer
10.1056/nejmoa1915103 · 2020 · External reference
Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer
10.1056/nejmoa025313 · 2003 · External reference
Edoxaban for the treatment of cancer-associated venous thromboembolism
10.1056/nejmoa1711948 · 2018 · External reference
Clinical review: inferior vena cava filters in the age of patient-centered outcomes
10.3109/07853890.2013.832951 · 2013 · External reference
Prevalence of fracture and fragment embolization of Bard retrievable vena cava filters and clinical implications including cardiac perforation and tamponade
10.1001/archinternmed.2010.316 · 2010 · External reference
Venous thrombotic, thromboembolic, and mechanical complications after retrievable inferior vena cava filters for major trauma
10.1093/bja/aeu195 · 2015 · External reference
Association between contemporary trends in inferior vena cava filter placement and the 2010 US Food and Drug Administration advisory
10.1001/jamainternmed.2017.2719 · 2017 · External reference
Cohort studies
2008 · External reference
Nationwide patterns of hemorrhagic stroke among patients hospitalized with brain metastases: influence of primary cancer diagnosis and anticoagulation
2020 · External reference
Lifetime occurrence of brain metastases arising from lung, breast, and skin cancers in the elderly: a SEER-Medicare study
10.1158/1055-9965.epi-18-1116 · 2019 · External reference
Inferior vena cava filters in patients with cancer and venous thromboembolism (VTE): patterns of use and outcomes
10.1016/s0049-3848(16)30112-8 · 2016 · External reference
Inpatient versus outpatient acute venous thromboembolism management: trends and postacute healthcare utilization from 2011 to 2018
2021 · External reference
Rate and duration of hospitalization for deep vein thrombosis and pulmonary embolism in real-world clinical practice
10.3109/07853890.2015.1085127 · 2015 · External reference
Outpatient management in patients with venous thromboembolism with edoxaban: a post hoc analysis of the Hokusai-VTE study
10.1160/th17-05-0523 · 2017 · External reference
Admission rates for emergency department patients with venous thromboembolism and estimation of the proportion of low risk pulmonary embolism patients: a US perspective
10.15441/ceem.15.096 · 2016 · External reference
